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Abstract
Objectives
Present study examines the relationship between the estimated risk of developing type 2
diabetes (T2D) and health-related quality of life (HRQoL). We quantify the association
between Finnish Diabetes Risk Score (FINDRISC) and HRQoL, and examine the potential
use of FINDRISC as tool to evaluate HRQoL indirectly.
Methods
We conducted a cross-sectional study comprising 707 Finnish people without a diagnosis
of T2D between the ages of 51 and 75 years. The risk of developing T2D was assessed
using the validated and widely used FINDRISC (range 0–26 points), and quality of life was
measured using two preference-based HRQoL instruments (15D and SF-6D) and one
health profile instrument (SF-36). Effects of the individual FINDRISC items and demo-
graphic and clinical characteristics, such as co-morbidities, on HRQoL were studied using
multivariable Tobit regression models.
Results
Low HRQoL was significantly and directly associated with the estimated risk of developing
T2D. An approximate 4–5 point change in FINDRISC score was observed to be associated
with clinically noticeable changes in the preference-based instrument HRQoL index scores.
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The association between HRQoL and the risk of developing T2D was also observed for
most dimensions of HRQoL in all applied HRQoL instruments. Overall, old age, lack of
physical activity, obesity, and history of high blood glucose were the FINDRISC factors
most prominently associated with lower HRQoL.
Conclusions
The findings may help the health care professionals to substantiate the possible improve-
ment in glucose metabolism and HRQoL potentially achieved by lifestyle changes, and bet-
ter convince people at high risk of T2D to take action towards healthier lifestyle habits.
FINDRISCmay also provide an accurate proxy for HRQoL, and thus by estimating the risk
of T2D with the FINDRISC, information about patients’ HRQoL may also be obtained indi-
rectly, when it is not feasible to use HRQoL instruments.
Introduction
Health-related quality of life (HRQoL) is an evolving, multidimensional construct of physical,
psychological and functional well-being that is increasingly used as an outcome in effectiveness
research examining the effects of a disease or intervention on individuals’ health [1]. Particu-
larly useful are preference-based HRQoL instruments (i.e., so-called health utility measures)
that can be used to estimate quality-adjusted life years (QALYs) for cost-utility evaluations [2].
In essence, these measures are generic in the sense that they can be reliably applied to any dis-
ease entity and also consider population preferences concerning various health states.
Unhealthy lifestyle habits, such as poor diet and physical inactivity, are among the leading
causes of mortality and disability in the Western world [3] and are also partly responsible for
the increasing epidemic of type 2 diabetes (T2D) and other obesity-related morbidities.
Although the preference-based HRQoL effects of T2D and prediabetes have been examined
previously [4,5], the association between estimated diabetes risk and HRQoL is less under-
stood. A few previous studies have reported an association between overall lifestyle and
HRQoL [6,7], but no study has evaluated the association between the estimated T2D risk and
HRQoL. While the effects of some individual lifestyle factors causing diabetes, such as physical
inactivity [8] and obesity [9], on HRQoL have been examined before, it is clinically more rele-
vant to examine the combined effect of multiple concurrent risk factors in multifactorial dis-
eases such as T2D.
Several non-invasive screening questionnaires for assessing the risk of T2D have been devel-
oped in the past ten years [10,11]. Compared to invasive tools, these questionnaires provide a
feasible method to routinely screen the population to detect individuals with either undetected
T2D, abnormal glucose metabolism or an elevated risk to develop T2D in the future. Although
most T2D risk questionnaires share similar characteristics and constructs, the Finnish Diabetes
Risk Score (FINDRISC) [12] is currently one of the most widely validated and utilized T2D
risk score [10,11].
Although the FINDRISC was originally developed to assess future T2D risk, subsequent
studies have shown that it can also be used to detect prevalent abnormal glucose metabolism
[13,14] and predict other significant health outcomes, such as coronary heart disease, stroke
and overall mortality [15,16]. These conditions can have a profound impact on an individual’s
expected life span and future quality of life, but a direct comparison of the FINDRISC and
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HRQoL scores has not been reported previously. Since FINDRISC is a feasible tool for estimat-
ing patients’ T2D risk in routine clinical practice, it could potentially also provide a simple way
to evaluate patients HRQoL in clinical work and research, when the use of additional separate
HRQoL questionnaires would not be feasible.
The present study had two aims. First, we sought to quantify how HRQoL may be associated
with the estimated T2D risk by examining the relationship between the FINDRISC score and
two validated preference-based HRQoL instruments, the 15D and the SF-6D, as well as one
health profile instrument, SF-36. Second, we wanted to provide a method to estimate the
HRQoL scores of these two preference-based instruments by using the FINDRISC score as a
proxy.
Methods
Study Design, Study Population and Data Collection
The analysis sample of the present study comprised 707 individuals who participated at the
10-year follow-up visit of the Savitaipale Study in 2007–2008 (Fig 1) [17]. The original study
population in the longitudinal observational Savitaipale Study consisted of the residents of the
municipality of Savitaipale, Finland who were born between 1933 and 1956. At the time of the
10-year follow-up visit, 74 individuals had died and 158 discontinued follow-up for unreported
reasons. An additional 213 people were excluded from the analyses either because they had
been diagnosed with diabetes (n = 110) or because full data to calculate the FINDRISC score
were not available (n = 103).
The data were obtained through a questionnaire and laboratory assays and diagnostic tests
during the study visit. All participants not treated with glucose-lowering drugs underwent an
oral glucose tolerance test (OGTT), which was conducted and interpreted using the WHO
1999 classification criteria using plasma glucose. Additionally, a retrospective review of patient
records was conducted for all participants, and co-morbidities were recorded using the Elix-
hauser co-morbidity index [18]. Depressive symptoms were evaluated with a Finnish transla-
tion of the original Beck Depression Inventory (BDI) [19]. Consequently, diabetes and
depression were omitted from Elixhauser morbidities, as these were assessed separately.
All study participants gave their informed consent in writing prior to their inclusion in the
study. All study protocols and informed consent procedures were approved by the ethics com-
mittee of the South Karelia District of Social and Health Services (decision number 24/98).
Diabetes Risk
We examined the T2D risk using the FINDRISC, a validated and widely used composite T2D
risk score questionnaire that comprises questions on age; body mass index (BMI); waist cir-
cumference; physical activity; consumption of fruits, berries or vegetables; and history of anti-
hypertensive medication, history of high blood glucose and family history of diabetes [12]. The
categorical response options are given weights (higher levels indicate greater significance) and
then summed to obtain the total risk score. The total score ranges from 0 to 26, in which a
higher score corresponds to a greater diabetes risk.
In the present study, the FINDRISC score was computed for each participant retrospec-
tively. The item concerning the consumption of fruits, berries or vegetables was not included in
the study questionnaire in a meaningful way and hence was omitted from the risk score.
Although study participants underwent an OGTT, the history of a high blood glucose level was
based on the participants’ own report, as intended in the original FINDRISC form.
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Health-Related Quality of Life
During the study visit, HRQoL was evaluated with two different questionnaires: the Finnish
15D [20] and the RAND-36 Item Health Survey v. 1.0 [21] (SF-36), which was also used to
derive a preference-based index score SF-6D [22,23].
The 15D is a generic, standardized and self-administered preference-based measure of
HRQoL and yields a single index score (also known as health utility), as well as a 15-dimen-
sional HRQoL profile. The 15D comprises 15 questions (dimensions): mobility, vision, hearing,
breathing, sleeping, eating, speech, excretion, usual activities, mental function, discomfort and
symptoms, depression, distress, vitality and sexual activity; each has five answer options [20].
The index score is obtained by weighting these dimensional scores with population-based pref-
erence weights based on an application of the multi-attribute utility theory [20]. The 15D
index and profile scores have values on a scale between 0 (representing HRQoL equal to being
dead) and 1 (representing best possible HRQoL).
Fig 1. Flow diagram of the participants included in the study sample. FINDRISC: Finnish Diabetes Risk Score. 1) FINDRISC question regarding the
consumption of fruits, berries and vegetables was omitted.
doi:10.1371/journal.pone.0147898.g001
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Although the 15D is a validated instrument and has been demonstrated to perform at least
equally well as similar types of generic HRQoL instruments [24], we also employed the widely
used SF-36 for wider comparability. The SF-36 is a 36-item questionnaire that is summarized
in eight dimension scores: general health, bodily pain, emotional role limitation, physical role
limitation, mental health, vitality, physical functioning and social functioning [21]. Each
dimension score has values between 0 and 100, in which 0 means dead and 100 perfect health.
Furthermore, the SF-36 was also used to derive its preference-based derivate, the SF-6D, as
described by Brazier et al. [22,23]. As with the 15D, SF-6D values vary between 0 and 1.
To aid the practical interpretation of abstract HRQoL measures, the estimated minimum
important differences (MID) can be used. Generally, the MID describes the minimum practi-
cally or clinically meaningful change in HRQoL score that an individual or a health care profes-
sional can notice. Alanne et al. [25] recently concluded that a difference of 0.015 or more can
be considered the MID for the 15D index score. This value also corresponds well with an esti-
mate based on 0.2xSD (standard deviation) as proposed by Fayers & Hays [26], if applied to
our study sample (0.20.077 = 0.0154). The MID threshold of 0.027 for the SF-6D proposed
by Luo et al. [27] concurs well with the above-mentioned 0.2xSD method applied to our study
sample (0.20.115 = 0.0230) and thus seems comparable with the 15D’s MID estimate.
Statistical Methods
Bivariate associations were examined using the Chi-squared test (categorical variables) and
Jonckheere’s trend-test (ordinal vs. continuous variables). The relationship between the FIN-
DRISC score and HRQoL was described graphically using means and confidence intervals
(CI). The significance of linear trend between HRQoL and the FINDRISC score was assessed
by fitting linear regression lines to the data.
To estimate the effects of the individual FINDRISC items, multivariable regression models
were created using HRQoL index scores (15D and SF-6D, in separate models) as dependent
variables and the FINDRISC items as independent variables. Tobit regression was used to
account for the ceiling effect commonly associated with HRQoL measures [28]. For further
analysis, age, sex, socioeconomic factors (cohabiting and employment status), and morbidities
(depressive symptoms, glucose metabolism status, number of other morbidities) were included
in the model. The variance in regression coefficients was estimated using the bootstrap proce-
dure with 1,000 replications.
To scope the accuracy of model estimates, two metrics are reported. The percentage mean bias
(and 95% confidence interval) in model predictions (ŷ) for each model is given by (ŷ –y) / y 100,
where ŷ is the modeled estimate and y is the observed HRQoL score. In essence, this metric
describes howmuch the model estimates differ from the actual observed values on a percentage
scale. Additionally, we report squared root mean error (RMSE),
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n1  Pðy^  yÞ2
q
, which is a
similar yet more widely utilized metric.
All analyses were conducted using Intercooled STATA 9.2, whereas IBM SPSS Statistics v.
21.0 and SAS 9.2 were also used to manage the data. The conventional value of p< 0.05 was
used as the threshold for statistical significance.
Results
Descriptive Statistics
On average (SD), study subjects were 62.3 (6.7) years old, had average BMI of 26.4 (4.0) kg/m2.
Overall, 44.0% of the study subjects were male. Although 24.5% of the subjects had at least two
morbidities, 41.5% of the subjects did not have any morbidities identified by the Elixhauser
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index. The study sample characteristics are described in relation to FINDRISC categories in
Table 1. The mean (SD) and median (range) FINDRISC scores were 14.8 (4.23) and 15 (2 to
25), respectively. Overall, 95% (n = 672/707) of the observed FINDRISC scores were between 6
and 22. The mean (SD) and median (range) 15D index values were 0.910 (0.077) and 0.926
(0.564 to 1), respectively. The mean and median SF-6D values were 0.770 (0.115) and 0.780
(0.487 to 1), respectively. The observed ceiling effect was modest in both HRQoL index
Table 1. The characteristics of the participants across the diabetes risk (FINDRISC) categories.
Finnish Diabetes Risk Score (FINDRISC)
Less than 7 7–11 12–14 15–20 More than 20
Variable (n = 19) (n = 165) (n = 137) (n = 324) (n = 62) p*
Age
45 to 54 years 3 (15.8) 35 (21.2) 29 (21.2) 18 (5.6) 2 (3.2) < 0.001
55 to 64 years 10 (52.6) 84 (50.9) 74 (54.0) 167 (51.5) 18 (29.0)
Older than 64 years 6 (31.6) 46 (27.9) 34 (24.8) 139 (42.9) 42 (67.7)
Body mass index 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Less than 25 kg/m2 18 (94.7) 129 (78.2) 53 (38.7) 80 (24.7) 0 (0.0) < 0.001
25–30 kg/m2 1 (5.3) 34 (20.6) 77 (56.2) 181 (55.9) 24 (38.7)
More than 30 kg/m2 0 (0.0) 2 (1.2) 7 (5.1) 63 (19.4) 38 (61.3)
Waist circumference
Less than 94 cm for men / 80 cm for women 16 (84.2) 127 (77.0) 20 (14.6) 47 (14.5) 0 (0.0) < 0.001
94–102 cm for men / 80–88 cm for women 3 (15.8) 22 (13.3) 83 (60.6) 104 (32.1) 5 (8.1)
More than 102 cm for men / 88 cm for women 0 (0.0) 16 (9.7) 34 (24.8) 173 (53.4) 57 (91.9)
Less than 30 minutes of daily physical activity 0 (0.0) 8 (4.8) 10 (7.3) 30 (9.3) 13 (21.0) 0.002
History of blood pressure medication 14 (73.7) 140 (84.8) 98 (71.5) 275 (84.9) 58 (93.5) 0.001
History of high blood glucose 0 (0.0) 126 (76.4) 122 (89.1) 303 (93.5) 62 (100.0) < 0.001
Family diabetes
No history of family diabetes 19 (100.0) 160 (97.0) 117 (85.4) 126 (38.9) 0 (0.0) < 0.001
2nd degree relative 0 (0.0) 0 (0.0) 1 (0.7) 6 (1.9) 1 (1.6)
1st degree relative 0 (0.0) 5 (3.0) 19 (13.9) 192 (59.3) 61 (98.4)
Male 12 (63.2) 84 (50.9) 59 (43.1) 135 (41.7) 21 (33.9) 0.052
Single, separated or widowed† 4 (21.1) 48 (29.6) 37 (27.0) 82 (25.7) 15 (24.6) 0.857
Employment status
Employed full-time or part-time 13 (68.4) 110 (69.2) 92 (67.6) 176 (56.2) 16 (26.2) < 0.001
Retired 5 (26.3) 41 (25.8) 29 (21.3) 94 (30.0) 34 (55.7)
Unemployed or on disability pension 1 (5.3) 8 (5.0) 15 (11.0) 43 (13.7) 11 (18.0)
Data missing 0 6 1 11 1
Glucose metabolism status
Normal glucose metabolism 15 (78.9) 123 (74.5) 99 (72.3) 232 (71.6) 31 (50.0) 0.016
Increased fasting glucose 3 (15.8) 11 (6.7) 15 (10.9) 26 (8.0) 6 (9.7)
Impaired glucose tolerance 1 (5.3) 21 (12.7) 19 (13.9) 48 (14.8) 20 (32.3)
Screen detected type 2 diabetes 0 (0.0) 10 (6.1) 4 (2.9) 18 (5.6) 5 (8.1)
Beck's Depression Inventory (BDI), mean (SD) 4.3 (4.3) 4.9 (4.6) 5.6 (6.1) 5.8 (5.4) 7.12 (5.93) < 0.001
Number of morbidities, mean (SD) 0.4 (0.5) 0.6 (0.8) 0.8 (0.9) 1.0 (1.0) 0.9 (1.0) < 0.001
Data are presented as n (%), unless otherwise indicated. SD: Standard deviation. FINDRISC: Finnish Diabetes Risk Score
*) Chi-squared test for categorical variables, Jonckheere’s trend test for Beck's Depression Inventory and number of morbidities.
†) In relation to married or cohabited individuals, data missing for 0+3+0+5+1 = 9 individuals.
doi:10.1371/journal.pone.0147898.t001
Does Future Diabetes Risk Impair Current Quality of Life?
PLOS ONE | DOI:10.1371/journal.pone.0147898 February 3, 2016 6 / 15
measures: 8.5% (n = 54/639) and 3.2% (n = 20/623) of the study subjects had a HRQoL score of
1 in the 15D and SF-6D, respectively.
Relationship between Overall Diabetes Risk and HRQoL
Both the 15D and SF-6D indices were significantly and directly associated with the FINDRISC
score (Fig 2). The association was reasonably linear, and on average, a one-point increase in
the FINDRISC score corresponded to a change of -0.0035 (95% CI: -0.0051 to -0.0020) and
-0.0055 (-0.0076 to -0.0033) in the 15D and SF-6D scores, respectively. An approximate 4–5
point change in the FINDRISC score was associated with noticeable changes in both the 15D
and SF-6D scores on average. Adjustment for sex, employment and cohabiting modified the
associations slightly; the mean (95% CI) adjusted coefficients were -0.0028 (-0.0043 to -0.0014)
and -0.0046 (-0.0068 to -0.0023) for the 15D and SF-6D, respectively.
An association between the HRQoL and FINDRISC score was observed for most dimen-
sions of HRQoL. Whereas nine of fifteen 15D dimensions were significantly associated with
the FINDRISC score, the sensory dimensions (seeing, hearing), ability to eat (eating) or speak
(speech), and feelings of anxiety (distress) or vitality (vitality) were not (Fig 3). Of the SF-36
dimensions, all but mental health were significantly associated with the FINDRISC score (Fig
4). Although statistically significant, the association between the SF-36 vitality dimension and
the FINDRISC score was noticeably weaker than that with other SF-36 dimensions.
Individual Risk Factors and Their Impact on HRQoL
In the multivariable analysis, the findings were similar for the 15D (Table 2) and SF-6D
(Table 3). Overall, old age, lack of physical activity, obesity and history of high blood glucose
Fig 2. Observed mean HRQoL index values and fitted linear trends (95% CI) in relation to the FINDRISC scores. Linear trends were fitted to data using
Tobit regression. The corresponding variance was estimated using a bootstrap procedure with 1,000 replications.*Adjusted for sex, employment and
cohabiting. HRQoL: Health-related quality of life. FINDRISC: Finnish Diabetes Risk Score.
doi:10.1371/journal.pone.0147898.g002
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were the FINDRISC factors most prominently associated with lower HRQoL. When socioeco-
nomic factors and morbidities were included in the model (full model), the associations
between the FINDRISC items and HRQoL were weakened. A small bias (difference between
model estimates and observed values) was present in all models, although it appeared to be
negligible; the average bias ranged from 0.5% to 1.1% in the 15D models and 2.0% to 2.8% in
the SF-6D.
The results of the multivariable models presented here should be interpreted with caution,
as they represent the independent associations (i.e. marginal effects) between each individual
model covariate and HRQoL measures, when the average effects of all other covariates included
in the model have been adjusted for. For instance, this means that less than 30 minutes of daily
physical activity is independently associated with a mean (95% CI) decrease of 0.025 (-0.052 to
0.002) in HRQoL, regardless of the patient’s age, BMI, depressive symptoms, number of mor-
bidities or any other variable included in the model. However, risk factors for T2D and morbid-
ities associated with T2D are rarely independently present. Instead, multiple risk factors are
inherently concurrently present as FINDRISC scores increase. Whereas the individual FIN-
DRISC items are naturally more prevalent at higher FINDRISC scores, the prevalence of
abnormal glucose metabolism, depressive symptoms and the number of other morbidities was
also significantly increased with a higher FINDRISC score (Table 1). Additionally, higher BMI
categories alone were significantly associated with a lack of physical activity (Pearson’s chi-
squared test: Chi2 = 15.48, p< 0.001), prevalence of abnormal glucose metabolism
Fig 3. Mean observed HRQoL (15D) dimension values in relation to the FINDRISC score. Linear trends were fitted to data using ordinary least squares
regression. The corresponding variance was estimated using a bootstrap procedure with 1,000 replications. HRQoL: Health-related quality of life. FINDRISC:
Finnish Diabetes Risk Score.
doi:10.1371/journal.pone.0147898.g003
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(Chi2 = 10.55, p = 0.005), as well as higher degree of depressive symptoms (Jonckeere’s trend
test: J = 2.03, p = 0.021) and number of other morbidities (J = 4.817, p<0.001).
Discussion
This study is the first to examine the relationship between HRQoL and the estimated diabetes
risk using the FINDRISC, a widely validated and utilized non-invasive diabetes risk assessment
tool. We found that the FINDRISC score was inversely associated with HRQOL indices overall,
as well as with most dimensions of both the 15D and SF-36. Our findings have two important
practical implications. First, the FINDRISC has the potential to be a readily applicable and fea-
sible proxy measure for HRQOL in both research and clinical purposes. This would allow a
practical way to evaluating HRQOL, when it is not feasible to burden patients with additional
HRQOL questionnaires, as well as allow additional post-hoc analyses when HRQOL question-
naires have not been employed. Second, our findings suggest that FINDRISC could potentially
to be used to quantify the potential HRQoL -impact of the life style changes. Our data show
that the 4 to 5 point decrease in FINDRISC is associated with clinically noticeable changes in
the preference-based instrument HRQoL index scores. This could help health care profession-
als substantiate the potential benefits of life style change to their patients.
Our findings are supported by another study that reported an association between overall
unhealthy lifestyle habits and poor 15D score [7]. Furthermore, our findings are also supported
by previous studies that have showed associations between poor HRQoL and physical inactivity
[8], obesity [9] and overall life-style pattern [6].
Our observation that BMI and waist circumference were not associated with poor HRQoL
after the data were adjusted for depressive symptoms, number of morbidities and current
Fig 4. Mean observed HRQoL (SF-36) dimension values in relation to FINDRISC. Linear trends were fitted to data using ordinary least squares
regression. The corresponding variance was estimated using a bootstrap procedure with 1,000 replications. HRQoL: Health-related quality of life. FINDRISC:
Finnish Diabetes Risk Score.
doi:10.1371/journal.pone.0147898.g004
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Table 2. Marginal effects of FINDRISC items and other covariates on the 15D HRQoL index.
Variable FINDRISC
weight
FINDRISC items Socioeconomic factors Full model
b (95% CI) b (95% CI) b (95% CI)
Age
45 to 54 years 2 ref. ref. ref.
55 to 64 years 3 -0.011 (-0.028;
0.005)
-0.005 (-0.021;
0.012)
0.002 (-0.011;
0.015)
Older than 64 years 4 -0.035*** (-0.053;
-0.016)
-0.029** (-0.051;
-0.007)
-0.001 (-0.020;
0.017)
Body mass index
Less than 25 kg/m2 0 ref. ref. ref.
25–30 kg/m2 1 -0.004 (-0.021;
0.013)
-0.005 (-0.025;
0.014)
-0.007 (-0.020;
0.007)
More than 30 kg/m2 3 -0.029* (-0.057;
-0.001)
-0.029* (-0.056;
-0.001)
-0.017 (-0.038;
0.004)
Waist circumference
Less than 94 cm for men / 80 cm for
women
0 ref. ref. ref.
94–102 cm for men / 80–88 cm for
women
3 -0.001 (-0.019;
0.016)
0.003 (-0.015;
0.021)
0.000 (-0.013;
0.014)
More than 102 cm for men / 88 cm for
women
4 -0.006 (-0.028;
0.016)
-0.003 (-0.026;
0.020)
0.002 (-0.015;
0.019)
Less than 30 minutes of daily physical
activity
2 -0.048*** (-0.073;
-0.022)
-0.042** (-0.067;
-0.017)
-0.023* (-0.043;
-0.003)
History of blood pressure medication 2 0.016 (-0.003;
0.035)
0.012 (-0.007;
0.031)
-0.006 (-0.020;
0.009)
History of high blood glucose 5 -0.018 (-0.035;
0.000)
-0.017 (-0.036;
0.002)
-0.015* (-0.028;
-0.003)
Family diabetes
No history of family diabetes 0 ref. ref. ref.
2nd degree relative 3 -0.037 (-0.108;
0.033)
-0.043 (-0.110;
0.025)
-0.018 (-0.070;
0.035)
1st degree relative 5 -0.006 (-0.019;
0.007)
-0.001 (-0.013;
0.012)
-0.005 (-0.015;
0.004)
Male 0.003 (-0.010;
0.016)
-0.011* (-0.021;
-0.001)
Single, separated or widowed† 0.003 (-0.012;
0.018)
0.003 (-0.009;
0.015)
Employment status
Employed full-time or part-time ref. ref.
Retired -0.004 (-0.022;
0.014)
0.003 (-0.011;
0.016)
Unemployed or on disability pension -0.072*** (-0.098;
-0.046)
-0.037*** (-0.058;
-0.017)
Beck's Depression Inventory (BDI) -0.009*** (-0.010;
-0.008)
Number of morbidities -0.019*** (-0.026;
-0.012)
Glucose metabolism status
Normal glucose metabolism ref.
Increased fasting glucose 0.009 (-0.004;
0.023)
(Continued)
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glucose metabolism status suggest that obesity itself is associated with a higher degree of vari-
ous co-morbidities that reduce quality of life. Furthermore, the results of our multivariable
analyses also suggest that the poor HRQoL associated with prediabetic stages in previous stud-
ies [4,5] may be mediated through underlying physical inactivity and obesity. In addition, it
should be also noted, that the physical inactivity and obesity are themselves induced by some
underlying cause–be it a physical condition preventing adequate exercise or some psychologi-
cal factor. Overall, in clinical practice, it is always important to identify the unique key factors
contributing to patient’s individual health status in order to aid patient effectively.
Interestingly, our data show that a previously detected high blood glucose level is statistically
and clinically significantly associated with lower HRQoL on both the 15D and SF-6D, regard-
less of the current glucose metabolism status. Whereas the OGTT is a valid tool for describing
a patient’s current glucose metabolism status, a self-reported history of high blood glucose may
indicate ongoing problems in glucose metabolism and may also reflect the individual’s worry
about their own health and wellbeing.
The present study has strengths and some potential weaknesses. First, we applied widely
used and validated instruments for both diabetes risk and HRQoL. Second, we examined
HRQoL with three different instruments, covering both preference-based HRQoL as well as
more descriptive HRQoL profiles. Additionally, we also considered the potential HRQoL
effects of socioeconomic factors and co-morbidity. The greatest weakness of the present study
was the cross-sectional setting, which did not allow us to examine the changes in HRQoL over
time in people with various FINDRISC scores. This prevents us from making any conclusions
on the causal pathways. A longitudinal examination of HRQoL in relation to the FINDRISC
score may also tell more about its validity as a predictor of future HRQoL. Additionally, our
study sample only comprised middle-aged and older individuals from one Finnish municipal-
ity. Although this can be seen as a weakness, the study sample is representative with a high par-
ticipation rate and comprises a homogenous set of individuals from the age strata in which the
prevalence of glucose metabolism disorders is highest.
Table 2. (Continued)
Variable FINDRISC
weight
FINDRISC items Socioeconomic factors Full model
b (95% CI) b (95% CI) b (95% CI)
Impaired glucose tolerance 0.002 (-0.014;
0.018)
Screen detected type 2 diabetes -0.014 (-0.041;
0.013)
Constant 0.949*** (0.922; 0.976) 0.949*** (0.921; 0.976) 1.010*** (0.988; 1.033)
Number of observations 639 619 603
BIC -1111.627 -1088.229 -1404.084
RMSE 0.075 0.072 0.0537
Mean % bias (95% CI) 1.1 (1.11; 1.16) 1.0 (0.98; 1.03) 0.5 (0.49; 0.52)
Tobit model bootstrapped standard errors (1,000 replications). HRQoL: Health-related quality of life. FINDRISC: Finnish Diabetes Risk Score. 95% CI:
95% Conﬁdence intervals.BIC: Bayesian Information Criteria. RMSE: Root Mean Squared Error. Statistically signiﬁcant at
*) p < 0.05
**) p < 0.01
***) p < 0.001.
†) In relation to married or cohabited individuals, data missing for 0+3+0+5+1 = 9 individuals
doi:10.1371/journal.pone.0147898.t002
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Table 3. Marginal effects of FINDRISC items and other covariates on the SF-6D HRQoL index.
Variable FINDRISC
weight
FINDRISC items Socioeconomic factors Full model
b (95% CI) b (95% CI) b (95% CI)
Age
45 to 54 years 2 ref. ref. ref.
55 to 64 years 3 -0.014 (-0.041;
0.013)
-0.009 (-0.038;
0.021)
-0.001 (-0.025;
0.023)
Older than 64 years 4 -0.040** (-0.069;
-0.012)
-0.041* (-0.076;
-0.006)
-0.005 (-0.036;
0.027)
Body mass index
Less than 25 kg/m2 0 ref. ref. ref.
25–30 kg/m2 1 -0.003 (-0.031;
0.025)
-0.010 (-0.038;
0.018)
-0.012 (-0.036;
0.013)
More than 30 kg/m2 3 -0.029 (-0.069;
0.011)
-0.035 (-0.075;
0.006)
-0.017 (-0.052;
0.018)
Waist circumference
Less than 94 cm for males / 80 cm for
females
0 ref. ref. ref.
94–102 cm for males / 80–88 cm for
females
3 -0.020 (-0.048;
0.008)
-0.009 (-0.038;
0.019)
-0.012 (-0.037;
0.012)
More than 102 cm for males / 88 cm
for females
4 -0.021 (-0.057;
0.015)
-0.008 (-0.046;
0.030)
-0.002 (-0.035;
0.031)
Less than 30 minutes of daily exercise 2 -0.053** (-0.087;
-0.019)
-0.047** (-0.080;
-0.013)
-0.025 (-0.052;
0.002)
History of blood pressure medication 2 0.022 (-0.002;
0.047)
0.018 (-0.005;
0.042)
-0.003 (-0.023;
0.017)
History of high blood glucose 5 -0.036** (-0.060;
-0.012)
-0.037** (-0.064;
-0.010)
-0.030** (-0.053;
-0.007)
Family diabetes ref. ref. ref.
No history of family diabetes 0
2nd degree relative 3 -0.044 (-0.095;
0.007)
-0.055* (-0.106;
-0.004)
-0.029 (-0.074;
0.016)
1st degree relative 5 -0.008 (-0.026;
0.010)
-0.006 (-0.025;
0.013)
-0.013 (-0.029;
0.003)
Male 0.022* (0.003;
0.041)
0.007 (-0.011;
0.026)
Single, separated or widowed† -0.004 (-0.026;
0.018)
-0.002 (-0.020;
0.016)
Employment status
Employed full-time or part-time ref. ref.
Retired 0.012 (-0.016;
0.039)
0.019 (-0.005;
0.044)
Unemployed or on disability pension -0.070*** (-0.098;
-0.042)
-0.031* (-0.057;
-0.006)
Beck's Depression Inventory (BDI) -0.011*** (-0.012;
-0.009)
Number of morbidities -0.019*** (-0.027;
-0.010)
Glucose metabolism status
Normal glucose metabolism ref.
Increased fasting glucose -0.008 (-0.040;
0.023)
(Continued)
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The FINDRISC is a comprehensive yet non-invasive tool that can be used to estimate the
risk of T2D and other disorders of glucose metabolism [12–14], as well as many other morbidi-
ties and total mortality [15,16]. Previous studies have shown that a lifestyle intervention can
effectively prevent the onset of T2D [29] in patients with impaired glucose tolerance, especially
among individuals with a high FINDRISC score [30]. The findings of the present study indicate
that the FINDRISC is also inversely associated with the patients current HRQoL. On the other
hand, previous studies have demonstrated that the self-perceived health status is associated
with current [31] and future [32] impairments in glucose metabolism. By substantiating the
possible improvement in the glucose metabolism status and HRQoL achieved by lifestyle
changes, health care professionals may better convince people at high risk of T2D to take action
towards healthier lifestyle habits.
Our findings suggest that the FINDRISC may provide an accurate proxy for HRQoL at least
at the population level, although the accuracy and validity of the FINDRISC as a proxy for indi-
vidual-level HRQoL should be further evaluated in the future studies.
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Table 3. (Continued)
Variable FINDRISC
weight
FINDRISC items Socioeconomic factors Full model
b (95% CI) b (95% CI) b (95% CI)
Impaired glucose tolerance -0.002 (-0.028;
0.024)
Screen detected type 2 diabetes -0.040* (-0.079;
-0.001)
Constant 0.834*** (0.794;
0.875)
0.826*** (0.783;
0.869)
0.896*** (0.859;
0.932)
Number of observations 623 601 586
BIC -773.1708 -748.9918 -903.6617
RMSE 0.1127 0.1111 0.0931
Mean % bias (95% CI) 2.8 (2.73; 2.82) 2.7 (2.66; 2.75) 2.0 (1.95; 2.03)
Tobit model, bootstrapped standard errors (1,000 replications). HRQoL: Health-related quality of life. FINDRISC: Finnish Diabetes Risk Score. 95% CI:
95% Conﬁdence intervals. BIC: Bayesian Information Criteria. RMSE: Root Mean Squared Error Statistically signiﬁcant at
* p<0.05
** p<0.01
*** p<0.001.
†) In relation to married or cohabited individuals, data missing for 0+3+0+5+1 = 9 individuals.
doi:10.1371/journal.pone.0147898.t003
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